These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 16267227)
21. The effect of the volatile oil from ginger rhizomes (Zingiber officinale), its fractions and isolated compounds on the 5-HT3 receptor complex and the serotoninergic system of the rat ileum. Riyazi A; Hensel A; Bauer K; Geissler N; Schaaf S; Verspohl EJ Planta Med; 2007 Apr; 73(4):355-62. PubMed ID: 17511060 [TBL] [Abstract][Full Text] [Related]
23. Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychotics. Appl H; Holzammer T; Dove S; Haen E; Strasser A; Seifert R Naunyn Schmiedebergs Arch Pharmacol; 2012 Feb; 385(2):145-70. PubMed ID: 22033803 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites. Molderings GJ; Schmidt K; Bönisch H; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):245-52. PubMed ID: 8878053 [TBL] [Abstract][Full Text] [Related]
25. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors. Oz M; Zhang L; Rotondo A; Sun H; Morales M Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235 [TBL] [Abstract][Full Text] [Related]
26. Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. Xiong W; Hosoi M; Koo BN; Zhang L Mol Pharmacol; 2008 Feb; 73(2):314-22. PubMed ID: 17993512 [TBL] [Abstract][Full Text] [Related]
27. Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Wetzel CH; Hermann B; Behl C; Pestel E; Rammes G; Zieglgänsberger W; Holsboer F; Rupprecht R Mol Endocrinol; 1998 Sep; 12(9):1441-51. PubMed ID: 9731711 [TBL] [Abstract][Full Text] [Related]
28. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. Oz M; Zhang L; Morales M Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042 [TBL] [Abstract][Full Text] [Related]
29. The C and E subunits of the serotonin 5-HT Yaakob NS; Nguyen DT; Exintaris B; Irving HR Biomed Pharmacother; 2018 Jan; 97():1701-1709. PubMed ID: 29793334 [TBL] [Abstract][Full Text] [Related]
30. Can 5-HT3 antagonists contribute toward the treatment of schizophrenia? Ellenbroek BA; Prinssen EP Behav Pharmacol; 2015 Feb; 26(1-2):33-44. PubMed ID: 25356732 [TBL] [Abstract][Full Text] [Related]
31. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism. Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134 [TBL] [Abstract][Full Text] [Related]
32. Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors. Rammes G; Hosp C; Eisensamer B; Tanasic S; Nothdurfter C; Zieglgänsberger W; Rupprecht R PLoS One; 2009 Aug; 4(8):e6715. PubMed ID: 19696922 [TBL] [Abstract][Full Text] [Related]
33. Characteristics of [14C]guanidinium accumulation in NG 108-15 cells exposed to serotonin 5-HT3 receptor ligands and substance P. Emerit MB; Riad M; Fattaccini CM; Hamon M J Neurochem; 1993 Jun; 60(6):2059-67. PubMed ID: 7684066 [TBL] [Abstract][Full Text] [Related]